Literature DB >> 26731216

Possibility of Müller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy.

Shintaro Nakao, Yasuhiro Ikeda, Yasunori Emi, Tatsuro Ishibashi.   

Abstract

Cystoid macular edema (CME) without leakage is an adverse complication of paclitaxel administration in patients with cancer. However, the mechanism of non-leaking CME has been unclear. The authors report the case of a 66-year-old man who developed non-leaking CME during treatment with paclitaxel for gastric cancer. This case report suggests possible pathogenesis of paclitaxel-induced CME without evidence of leakage at angiography from the data of electroretinogram. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26731216     DOI: 10.3928/23258160-20151214-14

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  3 in total

1.  Docetaxel Retinopathy: A Case Report.

Authors:  Sylvia Nghiem-Buffet; Salomon Yves Cohen; Audrey Giocanti-Auregan
Journal:  Case Rep Ophthalmol       Date:  2017-01-17

2.  Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.

Authors:  Chia-Hsin Shih; Yuan-Chieh Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  Paclitaxel may be a risk factor for retinal phototoxicity.

Authors:  Jonathan Malcolm; Caroline Oi Lune Wong; Jared Ching; Shohista Saidkasimova
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.